X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
non-pegylated liposomal doxorubicin (22) 22
oncology (16) 16
cardiotoxicity (15) 15
female (15) 15
humans (15) 15
doxorubicin - administration & dosage (14) 14
anthracyclines (13) 13
aged (12) 12
middle aged (12) 12
breast cancer (11) 11
breast neoplasms - drug therapy (11) 11
chemotherapy (11) 11
cyclophosphamide (11) 11
encapsulated doxorubicin (11) 11
index medicus (11) 11
adult (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
breast neoplasms - pathology (9) 9
conventional doxorubicin (9) 9
doxorubicin - analogs & derivatives (9) 9
treatment outcome (9) 9
metastatic breast cancer (8) 8
polyethylene glycols - administration & dosage (8) 8
paclitaxel (7) 7
cyclophosphamide - administration & dosage (6) 6
doxorubicin (6) 6
liposomes (6) 6
metastasis (6) 6
multicenter trial (6) 6
taxoids - administration & dosage (6) 6
cancer (5) 5
docetaxel (5) 5
kaplan-meier estimate (5) 5
neoplasm metastasis (5) 5
trastuzumab (5) 5
aged, 80 and over (4) 4
antibiotics, antineoplastic - administration & dosage (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
care and treatment (4) 4
clinical trials (4) 4
combination (4) 4
doxorubicin - adverse effects (4) 4
elderly-patients (4) 4
heart - drug effects (4) 4
hematology (4) 4
hematology, oncology and palliative medicine (4) 4
male (4) 4
product development (4) 4
reduced cardiotoxicity (4) 4
retrospective analysis (4) 4
retrospective studies (4) 4
rituximab (4) 4
therapy (4) 4
antibiotics, antineoplastic - therapeutic use (3) 3
breast neoplasms - mortality (3) 3
congestive-heart-failure (3) 3
corticosteroids (3) 3
doxorubicin - therapeutic use (3) 3
drug administration schedule (3) 3
epirubicin (3) 3
health aspects (3) 3
lymphomas (3) 3
neoplasm staging (3) 3
non-hodgkin's lymphoma (3) 3
non‐pegylated liposomal doxorubicin (3) 3
pharmacology & pharmacy (3) 3
prednisone (3) 3
prednisone - administration & dosage (3) 3
prognosis (3) 3
taxoids - adverse effects (3) 3
vincristine - administration & dosage (3) 3
1st-line chemotherapy (2) 2
1st-line therapy (2) 2
adjuvant treatment (2) 2
aged patients (2) 2
analysis (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
breast neoplasms - surgery (2) 2
cancer patients (2) 2
carcinoma, ductal, breast - drug therapy (2) 2
carcinoma, ductal, breast - secondary (2) 2
chemotherapy, adjuvant - adverse effects (2) 2
chop (2) 2
comorbidity (2) 2
diffuse large b-cell lymphoma (2) 2
diffuse large b‐cell lymphoma (2) 2
disease progression (2) 2
disease-free survival (2) 2
elderly (2) 2
heart failure - chemically induced (2) 2
internal medicine (2) 2
lymphoma, large b-cell, diffuse - drug therapy (2) 2
medicine & public health (2) 2
metastatic breast-cancer (2) 2
obstetrics & gynecology (2) 2
palliative treatment (2) 2
patients (2) 2
phase-iii trial (2) 2
predictive value of tests (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast, The, ISSN 0960-9776, 2016, Volume 31, pp. 186 - 191
Journal Article
European Journal of Haematology, ISSN 0902-4441, 06/2016, Volume 96, Issue 6, pp. 650 - 654
Plasmablastic lymphoma ( PBL ) is a rare subtype of non‐Hodgkin lymphomas ( NHL ) strongly associated with HIV infection, even if cases in other... 
plasmablastic lymphoma | non‐pegylated liposomal doxorubicin | response duration | bortezomib | Response duration | Plasmablastic lymphoma | Bortezomib | Non-pegylated liposomal doxorubicin | Cyclophosphamide | Anthracyclines | Corticosteroids | Lymphomas | Prednisone | HIV infection | Steroids
Journal Article
Journal Article
Oncology Letters, ISSN 1792-1074, 08/2016, Volume 12, Issue 2, pp. 1211 - 1215
Patients with non-platinum-sensitive recurrent ovarian cancer have a poor prognosis. Non-pegylated liposomal doxorubicin (Myocet (R)) is a promising drug that... 
Epithelial ovarian cancer | Non-pegylated liposomal doxorubicin | Platinum-resistant recurrence | PALMAR-PLANTAR ERYTHRODYSESTHESIA | MANAGEMENT STRATEGIES | ONCOLOGY | REFRACTORY OVARIAN | epithelial ovarian cancer | platinum-resistant recurrence | non-pegylated liposomal doxorubicin | PACLITAXEL
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 47, Issue 14, pp. 2091 - 2098
Journal Article
Journal Article
Journal Article
Breast, The, ISSN 0960-9776, 2010, Volume 19, Issue 5, pp. 333 - 338
Journal Article
International Journal of Immunopathology and Pharmacology, ISSN 0394-6320, 2013, Volume 26, Issue 3, pp. 773 - 778
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2009, Volume 64, Issue 2, pp. 401 - 406
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2011, Volume 154, Issue 5, pp. 579 - 589
This Phase II study assessed feasibility and efficacy of a biweekly R‐COMP‐14 regimen (rituximab, cyclophosphamide, non‐pegylated liposome‐encapsulated... 
non‐pegylated liposomal doxorubicin | cardiotoxicity | diffuse large B‐cell lymphoma | Charlson Comorbidity Index | elderly | Cardiotoxicity | Elderly | Non-pegylated liposomal doxorubicin | Diffuse large B-cell lymphoma | GUIDELINE UPDATE | AMERICAN-COLLEGE | diffuse large B-cell lymphoma | CHOP REGIMEN | non-pegylated liposomal doxorubicin | CHEMOTHERAPY | TROPONIN-I | COMORBIDITY | CARDIAC-DISEASES | NON-HODGKINS-LYMPHOMA | ANTHRACYCLINE-INDUCED CARDIOTOXICITY | ASSOCIATION TASK-FORCE | HEMATOLOGY | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prognosis | Comorbidity | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Rituximab | Lymphoma, Large B-Cell, Diffuse - complications | Male | Risk | Treatment Outcome | Polyethylene Glycols - administration & dosage | Heart Diseases - epidemiology | Doxorubicin - analogs & derivatives | Survival Analysis | Aged, 80 and over | Vincristine - administration & dosage | Female | Aged | Heart Diseases - drug therapy | Doxorubicin - administration & dosage | Anthracyclines | Cyclophosphamide | Corticosteroids | Stem cells | Aged patients | Transplantation | Lymphomas | Prednisone | Steroids | Index Medicus | Haematological Malignancy
Journal Article